About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Optimizing Sleep Health in Nurses | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNANCT05965609

Optimizing Sleep Health in Nurses

The aim of the proposed study is to pilot test two behavioral sleep intervention strategies for improving insomnia among night shift working nurses.

Lead sponsor: Oregon State University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Jessica R Dietch, PhD

CONTACT

541-737-1358 jessee.dietch@oregonstate.edu

Lucy Kozii, MD, MPH

CONTACT

koziil@oregonstate.edu

Sponsors

Lead Sponsor

Oregon State University

Collaborators

American Academy of Sleep Medicine
Monash University
Stanford University

Night shift nurses with insomnia who meet all study criteria will receive one of two insomnia therapies. The specific therapy for insomnia will be determine by chance (like a flip of a coin), with an equal chance to receive either cognitive-behavioral therapy for insomnia or multicomponent relaxation therapy for insomnia, both modified for shift workers. Both therapies will be conducted over telehealth by interventionists trained in behavioral sleep medicine.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Current shift working nursing staff in Oregon
•Expect to continue on shift work schedule during the study
•Meets criteria for an insomnia disorder
•Elevated insomnia symptoms
•Have daily access to internet on a smartphone, tablet, or computer; and
•Can read and write in English

Exclusion Criteria

•People with uncontrolled medical conditions
•Presence of safety risk or condition in which study participation may be ineffective or result in increased risk to safety
•Some current treatments for insomnia
•Permanent day, evening, or rotating shift schedule
•History of seizures or manic episode; or
•Current/expected pregnancy during the study period

Related studies

RECRUITINGPhase 4

Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress

NCT03642028 · Sleep Initiation and Maintenance Disorders, Stress Disorders, Posttraumatic

Evaluation of the Effectiveness of Patient Therapeutic Education on Chronic Insomnia

NCT05000528 · Sleep Initiation and Maintenance Disorders

RECRUITINGPhase 2

Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)

NCT05565833 · Insomnia, Cognitive Dysfunction, and more

Active Not Recruiting

A Study to Assess the Pregnancy Outcome in Women Exposed to Dayvigo® During Pregnancy Compared to an Unexposed Control Population

NCT06744673 · Sleep Initiation and Maintenance Disorders, Pregnancy

Not Yet RecruitingNA

A Transdiagnostic Sleep Health Intervention for Veterans With PTSD

NCT06549049 · Stress Disorders, Post-Traumatic, Sleep Initiation and Maintenance Disorders

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 20, 2025Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment60

Start dateDec 2023

Last updatedMar 20, 2025

Condition

Circadian Rhythm Sleep-Wake Disorders, Shift Work Type Sleep Initiation and Maintenance Disorders

Locations shown

Oregon State University

Corvallis, Oregon

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 20, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions